THURSDAY, July 13, 2023 — A preclinical study offers a potential new therapy for treatment-resistant prostate cancer, offering new hope for men with the disease.
The study used the chemotherapy drug cisplatin, administered orally, to disrupt the…
THURSDAY, July 13, 2023 — A preclinical study offers a potential new therapy for treatment-resistant prostate cancer, offering new hope for men with the disease.
The study used the chemotherapy drug cisplatin, administered orally, to disrupt the…